Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

CONTACT:

Gastric Breast Cancer Editorial Office, University of Ioannina, Ioannina 45110, Greece
Tel: +30 26510 97423
Fax: +30 26510 97094
E-mail.: info@gastricbreastcancer.com


THE BEGINNING
The idea for the development of this Web site and web journal was based on the need and desire of interested persons (medical professionals, researchers, students, individuals) to have valuable update clinical research and practice information online right at their desktop. GBCNC site and GBC web journal were founded in 2002 by Dr. Dimitrios H. Roukos, at Ioannina University School of Medicine.

MISSION

As a non-profit International Organization against Cancer, GBCNC’s mission is to provide free, open access to information and translational research to all interested individuals.

Non-profit International Organization against Cancer

Two are the major actions of non-profit Organization GBCNC founded in 2003 in Ioannina, Greece.

1. The GBCNC site

The site is dedicated to provide cutting edge research news, information and educational resource. GBCNC is focused primarily on gastric cancer and breast cancer. In 2004 will start to provide more general information on carcinogenesis, prevention, early detection, multidisciplinary, surgical oncology, new targeted molecular therapies and possible clinical implications of Genomics and Proteomics.

2. Gastric & Breast Cancer web journal

GBC is a specific, peer-reviewed oncology journal. Provides secondary-research articles on current best practice and future clinical and research directions on carcinogenesis-based prevention and early detection, and multidisciplinary, evidence-based management and treatment of breast cancer and gastric cancer.

Clinical judgment in controversial topics
Providing an update, comprehensive, critical, in-depth, analysis of all evidence available facilitates medical professionals and patients to decision-making on several topics.
For example, for clinicians to make decisions on chemoprevention, extent of surgery (limited vs. extended), use of adjuvant treatment before or after surgery etc…


Integrating exciting research into clinical practice – Perspective articles

There is currently a gap between research achievements and their incorporation into clinical use. GBC journal provides PERSPECTIVE articles evaluating critically the potential risks and benefits in patient’s outcomes by the integration of cutting edge research into clinical practice.

CONTENT

Gastric Breast Cancer covers a wide spectrum of stomach cancer and breast cancer from carcinogenic pathway-based chemoprevention and early detection to traditional multidisciplinary treatment and new targeted molecular therapies.

SECONDARY RESEARCH
GBC provides the following types of secondary-research articles:

Internationally recognized leading experts in the fields of gastric cancer and breast cancer from molecular biology to multidisciplinary treatment ensure a high scientific level of strongly selected articles published in the Journal. More information on short CVs

ACHIEVEMENTS


1. GBCNC site RANKING
Ranking 1
or Top 10 in all relevant search engines

  • Academic
    HONcode, (Geneva Univ.; www.hon.ch ): # 1 (gastric), # 3 (breast cancer)
    Omni (Nottingham Univ., UK; www.omni.ac.uk ).
  • Commercial
    Google, Yahoo, …. (#1 to # 10, according to key words used)

2. GBC web journal

GBC selection among 43 most relevant oncology web journals by:
Google Directory
ODP Directory

DYNAMIC
GBC's dynamic towards an international leading Website is reflected by a dramatically increasing number of GBC-members.
2004: New design with easy friendly access, fully revised site version (in progress)

2004(in progress)

New design with easy-friendly access, fully revised site version including the following topics:

  • Carcinogenesis
  • Prevention (familial, sporadic cancer)
  • Early detection
  • TREATMENT (early-stage (minimal inasive), advanced stage)
  • Multidisciplinary treatment (surgery, chemotherapy, radiotherapy), neoadjuvant therapy
  • Recurrence
  • New therapies (molecular targeted therapies, clinical trials)
  • Surgical Oncology (research and practice)
  • Genomics
GOAL
To evaluate and promote worldwide–through open, free access to GBCNC site and GBC web journal of all medical professionals and individuals- possible changes in the current management of gastric cancer and breast cancer that may result in reducing incidence and improving both survival and quality of Life.

A potential reduction in incidence can be achieved with design of effective prevention and chemoprevention strategies in the general population and an improvement in survival of patients with gastric cancer and breast cancer with appropriate multimodality treatment.

WHY TO REGISTER

You need few seconds for registration and have an open, free access to all full-text articles. From time to time you will receive per email early-release articles and table of contents of each new GBC issue.

SUPPORT

University of Ioannina, Ioannina, Greece

TECHNICAL SUPPORT
Unit of Medical Technology and Intelligent Information Systems at Ioannina University, Greece.

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.



Search only trustworthy HONcode health websites:

last update: 24 February 2011